| Add to balance / Manage account | User: | Log out |
| Prospect News home > News index > List of issuers P > Headlines for Purdue Pharma LP > News item |
Purdue Pharma operating profit increases to $26 million in October
By Caroline Salls
Pittsburgh, Nov. 21 – Purdue Pharma LP posted a $26 million operating profit for October on $79 million in net sales, according to its monthly operating report filed Wednesday with the U.S. Bankruptcy Court for the District of Delaware.
In comparison, the company reported a $16 million operating profit for September on $85 million in net sales.
Net income for October was $62,000, up from $25,000 of September net income.
In addition, Purdue listed $1,145,000,000 in cash and cash equivalents as of Oct. 31, up from $1,059,000,000 at the end of September.
Purdue Pharma is a Stamford, Conn.-based drug manufacturer. It filed for Chapter 11 bankruptcy on Sept. 15 under case number 19-23649.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.